verified SJR 1,237 · Q1 • database Scopus / SJR & Web of Science indexed

United States · Lippincott Williams and Wilk...

workspace_premium Q1 — Infectious Diseases lock Subscription

Current Opinion in HIV and AIDS

Current Opinion in HIV and AIDS is a journal indexed in SJR in Infectious Diseases and Immunology with an H index of 82. It has an SJR impact factor of 1,237 and it has a best quartile of Q1. It has an SJR impact factor of 1,237.

Current Opinion in HIV and AIDS focuses its scope in these topics and keywords: subsaharan, europeeditorial, antiretroviral, africaplanning, hivassociated, malignancies, prophylaxis, preexposure, drugstissue, existing, ...

ISSN: 1746-630X

Publisher: Lippincott Williams and Wilkins Ltd.

Category: Infectious Diseases

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

1,237 Q1

H-index 82

Acceptance rate pie_chart

27% Selective

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

NPD Subscription

Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

1,237

H-index

Docs (year)

Docs 3y

152

Total refs

4264

Cites 3y

510

Citable 3y

133

Cites/Doc 2y

3.5

Ref/Doc

62.71

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Biology of plasmacytoid dendritic cells and natural killer cells in HIV-1 infection

Virologic suppression in treatment-experienced patients after virologic rebound or failure of therapy

Editorial introductions

Drugs in traditional drug classes (nucleoside reverse transcriptase inhibitor/nonnucleoside reverse transcriptase inhibitor/protease inhibitors) with activity against drug-resistant virus (tipranavir, darunavir, etravirine)

Distinctive features of CD4+ T cell dysfunction in chronic viral infections

Direct-acting antiviral-based therapy for chronic hepatitis C virus in HIV-infected patients

Current World Literature

Current state and limitations of daily oral therapy for treatment

Curing HIV

Combined approaches for HIV cure

Characteristics of HIV epidemics driven by men who have sex with men and people who inject drugs

SHOW MORE ARTICLES

Cabotegravir long-acting for HIV-1 prevention

A cure for HIV

Beyond cure

Barriers to HIV treatment among people who use injection drugs

Application of gene-editing technologies to HIV-1

Antiretroviral therapy in treatment-na?Øve patients with HIV infection

Antiretroviral drug concentrations in the male and female genital tract: implications for the sexual transmission of HIV

Antibody engineering for increased potency, breadth and half-life

Antibodies for prevention of mother-to-child transmission of HIV-1

Antibodies for HIV prevention in young women

Analysis of biomarker data: logs, odds ratios, and receiver operating characteristic curves

Adeno-associated virus delivery of broadly neutralizing antibodies

FAQs

Current Opinion in HIV and AIDS has an SJR of 1,237 (best quartile Q1) in the CountryOfPapers database.

Immediate OA APC is not available (NPD).

The acceptance rate recorded for Current Opinion in HIV and AIDS is 27%.

Current Opinion in HIV and AIDS

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Current Opinion in HIV and AIDS?

What is the APC / publication cost?

What is the acceptance rate?